Erlotinib Cancer Treatment Drug
Links shared publicly online about this topic.
- 475total visits
Erlotinib Cancer Treatment Drug
View full resource at disabled-world.com
Tags: Cancer, Cancer Medication, Chemotherapy, Non-Small Cell Lung Cancer Medication, Drug, Tarceva
Most Recently Shared on February 27, 2011 at 6:38 pm By:
Erlotinib Cancer Treatment Drug http://ff.im/-yZx2j
Immunotherapy Drugs: Two Drugs Harness Immune System To Fight Cancer
huffingtonpost.com — “By Bill Berkrot NEW YORK, May 7 (Reuters) - More than 100 years after researchers first explored the potential to harness the body's immune system to fight cancer, the field's leading doctors see the concept finally proving itself on a large scale in the next year or two. Two drugs based on immunotherapy are already available and have met with mixed results. Bristol-Myers Squibb's Yervoy has been hailed as a major breakthrough for treatment of melanoma since its approval last year, w” View full resource at huffingtonpost.com
Most Recently Shared on May 7, 2012 at 8:30 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
Immunotherapy Drugs: Two Drugs Harness Immune System To Fight #Cancer http://t.co/KXQ728T9 via @HealthyLiving
Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
newswise.com — “A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for patients w” View full resource at newswise.com
Most Recently Shared on May 7, 2012 at 4:44 pm By:
#health news: Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets http://t.co/ebFOkm4e
FDA staff question Pfizer arthritis drug benefits | Reuters
in.reuters.com — “WASHINGTON (Reuters) - U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections.The” View full resource at in.reuters.com
Most Recently Shared on May 7, 2012 at 2:36 pm By:
FDA staff question Pfizer arthritis drug benefits http://t.co/WXFuqyft
Lower-Dose Radioiodine Effective Against Thyroid Cancer - Drugs.com MedNews
drugs.com — “People with thyroid cancer are often given a radioactive iodine treatment to wipe out stray cancer cells, a treatment that comes with its own health risks. Now,” View full resource at drugs.com
Most Recently Shared on May 3, 2012 at 12:04 am By:
Lower-Dose Radioiodine Effective Against Thyroid Cancer - http://t.co/DGZvzS4P
Pfizer says on lookout for mid-size drug deals | Reuters
reuters.com — “(Reuters) - Pfizer Inc, which last week agreed to sell its baby formula business for almost $12 billion, is on the hunt for companies with promising new treatments for diabetes, cancer and neurological” View full resource at reuters.com
Most Recently Shared on May 2, 2012 at 12:12 pm By:
Pfizer says on lookout for mid-size drug deals http://t.co/6ObLIc13
SMC rules abiraterone as too expensive for routine prostate cancer treatment
news-medical.net — “Cancer Research UK is extremely disappointed that the advanced prostate cancer drug, abiraterone, has been ruled too expensive for routine use by the Scottish Medicines Consortium (SMC).” View full resource at news-medical.net
Most Recently Shared on May 2, 2012 at 12:09 pm By:
SMC rules abiraterone as too expensive for routine prostate cancer treatment: Cancer Research UK is extremely di... http://t.co/Pr7gTjLe
Pfizer says on lookout for mid-size drug deals | Reuters
in.reuters.com — “(Reuters) - Pfizer Inc, which last week agreed to sell its baby formula business for almost $12 billion, is on the hunt for companies with promising new treatments for diabetes, cancer and neurological” View full resource at in.reuters.com
Most Recently Shared on May 2, 2012 at 11:43 am By:
Pfizer says on lookout for mid-size drug deals http://t.co/0U8jUFt2
Combination of new prostate cancer drugs can extend life for men
news-medical.net — “Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length of time they benefit, research led by The Institute of Cancer Research (ICR) has shown.” View full resource at news-medical.net
Most Recently Shared on May 2, 2012 at 10:07 am By:
Combination of new prostate cancer drugs can extend life for men: Combing two new prostate cancer drugs could in... http://t.co/ZXZktfuC
Pfizer says on lookout for mid-size drug deals | Reuters
in.reuters.com — “(Reuters) - Pfizer Inc, which last week agreed to sell its baby formula business for almost $12 billion, is on the hunt for companies with promising new treatments for diabetes, cancer and neurological” View full resource at in.reuters.com
Most Recently Shared on May 1, 2012 at 9:01 pm By:
Pfizer says on lookout for mid-size drug deals http://t.co/17jPNNv3
FDA OKs New Treatment for Soft-Tissue Sarcoma Patients - Health Blog - WSJ
blogs.wsj.com — “Patients with soft-tissue sarcoma, a rare cancer that starts in the body?s muscle or connective tissues, now have a new treatment option after the FDA approved GlaxoSmithKline?s drug Votrient.” View full resource at blogs.wsj.com
Most Recently Shared on April 27, 2012 at 7:09 pm By:
FDA OKs New Treatment for Soft-Tissue Sarcoma Patients http://t.co/6Mhq6F3S
Possible new cancer treatment identified
sciencedaily.com — “New research findings show how it may be possible to render cancer tumors harmless without affecting the other cells and tissues in the body. The findings apply to cancers including breast, lung and bowel cancer. Many of the most common chemotherapy drugs used to treat cancer have serious side effects because they not only affect the cells in the cancer tumor, but also the cells in the rest of the body.” View full resource at sciencedaily.com
Most Recently Shared on April 25, 2012 at 7:32 pm By:
Potential New Cancer Treatment Identified http://t.co/HyPp2pqF
Remembering Krebiozen: Why We Have Access to Unapproved Drugs and Why We Need Scientific Evidence | FDA Voice
blogs.fda.gov — “Remembering Krebiozen: Why We Have Access to Unapproved Drugs and Why We Need Scientific Evidence | FDA Voice” View full resource at blogs.fda.gov
Most Recently Shared on April 23, 2012 at 1:37 pm By:
RT @AlecGaffney: #FDA's Rich Pazdur has a REALLY well written take on using unproven treatments. http://t.co/k31JE9wq #Cancer #pharma
The Benefits of Reducing Chemotherapy - Video - iHealthTube.com
ihealthtube.com — “IPT is a cancer treatment that uses just a fraction of the chemotherapy drugs that are traditionally used. Dr. Les Breitman talks about the many benefits of using less chemo and potentially getting better results.” View full resource at ihealthtube.com
Most Recently Shared on April 17, 2012 at 6:29 pm By:
The Benefits of Reducing Chemotherapy - Video - http://t.co/5f8i4HLz http://t.co/r9nZDoNp
Endocyte could get $1B from Merck development deal - BusinessWeek
businessweek.com — “Endocyte Inc. said Monday that Merck & Co. will help develop and market its experimental cancer drug vintafolide, and Endocyte could get more than $1 billion if the drug is successfully developed as a treatment for multiple types of cancer.” View full resource at businessweek.com
Most Recently Shared on April 16, 2012 at 8:46 pm By:
Dr. P. D Tapp Doctor, Health Executive, and PhD
Merck to buy Endocyte cancer therapy for as much as $1B if tests are successful. http://t.co/cG7H3qTw
Nanostars Deliver Drug Directly to Cancer Cells
lurie.northwestern.edu — “Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that can deliver a drug directly to a cancer cell's nucleus -- an important feature for effective treatment.” View full resource at lurie.northwestern.edu
Most Recently Shared on April 11, 2012 at 7:57 pm By:
Dr. P. D Tapp Doctor, Health Executive, and PhD
Nrthwstrn-U scientists first to develop specialized nanoparticles to deliver drugs directly to cancer cell nuclei http://t.co/iD9Ef4B2
Advertisement
